Heart rhythm safety study of an experimental oral drug
This study tests a new oral drug to see how it affects the heart's rhythm in healthy adults. It helps make sure the drug is safe before it's tested in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 45 years old.
- Your body mass index (BMI) is between 19 and 28.
- You are in good health with no significant medical conditions.
- You are not pregnant or breastfeeding, and you agree to use effective birth control during the study.
- You have no history of heart rhythm problems or a family history of sudden cardiac death.
- You do not smoke more than 5 cigarettes a day and can stop during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This trial tests a new tablet drug in healthy people to see how safe it is and how the body processes it. It is an early-stage study, meaning it helps find the right dose and check for side effects.
This study checks if taking the experimental drug with food changes how it works in the body. It helps decide the best way to take the drug in future studies.
This study tests a new medicine called THRV-1268 to see if it can safely improve heart rhythm in people with Long QT syndrome types 2 and 3. It may help reduce the risk of dangerous heart rhythm problems.
This trial tests whether a new drug called XY0206 affects the heart's electrical activity (QTc interval). Healthy participants take either XY0206, a placebo, or a control drug to compare effects. It helps ensure the drug is safe for the heart before testing in patients.
This trial tests a new experimental drug (ISM4808) in healthy adults to see how safe it is and how the body handles it. It may help researchers learn if the drug is promising for future treatments.
Hear when a new Evaluation of QTc Interval trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.